Source: Annual Congress 2004 - Cystic fibrosis in the 21^st century: cutting edge investigations, taxing problems
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Grasemann, R. Schwirtz, K. Racké, F. Ratjen (Essen, Bonn, Germany). Arginase in patients with cystic fibrosis airway disease. Eur Respir J 2004; 24: Suppl. 48, 1353

Member's Comments

No comment yet.

Related content which might interest you: Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Airway inflammation in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 14-31 Year: 2014 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia Source: Eur Respir J 2016; 47: 829-836 Year: 2016 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Small airways disease in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=21 Year: 2006 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002